Versant Capital Management, Inc - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$2,000
+100.0%
110.0%0.00%
Q2 2020$1,0000.0%110.0%0.00%
-100.0%
Q1 2020$1,0000.0%110.0%0.00%0.0%
Q4 2019$1,0000.0%11
-50.0%
0.00%
Q3 2019$1,0000.0%220.0%0.00%
Q2 2019$1,000
-50.0%
22
-12.0%
0.00%
Q1 2019$2,000
+100.0%
25
+4.2%
0.00%
Q4 2018$1,0000.0%240.0%0.00%
Q3 2018$1,0000.0%240.0%0.00%
Q2 2018$1,0000.0%24
-7.7%
0.00%
Q1 2018$1,0000.0%26
-16.1%
0.00%
Q4 2017$1,0000.0%310.0%0.00%
-100.0%
Q3 2017$1,000
-50.0%
31
-24.4%
0.00%0.0%
Q2 2017$2,0000.0%410.0%0.00%0.0%
Q1 2017$2,0000.0%41
-25.5%
0.00%0.0%
Q4 2016$2,000
-60.0%
55
-41.5%
0.00%
-66.7%
Q3 2016$5,000
+66.7%
940.0%0.00%
+50.0%
Q2 2016$3,0000.0%94
-3.1%
0.00%0.0%
Q1 2016$3,000
-40.0%
97
-14.9%
0.00%
-33.3%
Q4 2015$5,0001140.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders